pneumococcal conjugate Clinical Research Trials

Found 5 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Includes pre-screening
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
enrolling by invitation

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) when it is given after 1 dose, 2 doses, or 3 doses of a licensed …

Accepts healthy volunteers

0 views
25 Apr, 2025

Multi-country trial
Phase 3
For pediatric ages
Recruiting in 1000s
Interventional Study
all
Recruiting

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

pneumococcal conjugate

conjugate vaccine

0 views
16 Feb, 2024
47 locations

Phase 2
For pediatric ages
Recruiting in 100s
Interventional Study
all
Recruiting

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

0 views
17 Nov, 2020
31 locations

For pediatric ages
For adults
Interventional Study
all
Recruiting

Nasopharyngeal Carriage of S. Pneumoniae

This nasopharyngeal (NP) carriage surveillance study was requested by the European Agency for the Evaluation of Medicinal Products as a post-licensing commitment to determine whether the use of the pneumococcal conjugate vaccines (PCVs) including 7 then 13 valents (introduced in 2001 and 2010, respectively) caused a shift in the distribution …

0 views
16 Feb, 2024
1 location

For pediatric ages
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

This study will evaluate the persistence of immunogenicity following a reduced dosing schedule of 10- or 13-valent Pneumococcal Conjugate Vaccine (PCV10, PCV13). This is the follow-up of a randomized controlled trial in which children received a single priming dose of PCV10 or PCV13 (at 6 or 14 weeks of age) …

pneumococcal conjugate

booster

pneumococcal